Product Information
PREDNISONE INTENSOL 5 MG/ML is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $3.2149 per ML under NDC 00054372144. Its NADAC has been published 235 times since Mar 18, 2015.
FDA first approved this application on Feb 20, 1985.
Strength
5 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054372144
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREDNISONEApproval Type
Generic (ANDA)
FDA Application
ANDA088810FDA Approved
2/20/1985
On Market Since
2/20/1985
Pharmacological Classes
Price Statistics
The NADAC for PREDNISONE INTENSOL 5 MG/ML has been published 235 times since Mar 18, 2015, and over the history we have for it it has risen 138.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2149 per ML |
|---|---|
| All-time high | $3.5760 (Jan 14, 2026) |
| All-time low | $1.3484 (Mar 18, 2015) |
| 52-week high | $3.5760 |
| 52-week low | $3.0625 |
| Median price | $3.1040 |
| Average price | $2.4758 |
| Largest weekly change | +96.9% (Apr 17, 2024) |
| Weeks tracked | 235 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PredniSONE Intensol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PredniSONE Intensol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREDNISONE INTENSOL 5 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for PREDNISONE INTENSOL 5 MG/ML, manufactured by Hikma Pharmaceuticals USA Inc., is $3.2149 per ML (NDC 00054372144), effective Sep 30, 2026.
How has the price of PREDNISONE INTENSOL 5 MG/ML changed over time?
Over the history we have for it, the NADAC for PREDNISONE INTENSOL 5 MG/ML has risen 138.4%. It has been tracked across 235 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for PREDNISONE INTENSOL 5 MG/ML?
Since Mar 18, 2015, the NADAC for PREDNISONE INTENSOL 5 MG/ML has ranged from a low of $1.3484 (Mar 18, 2015) to a high of $3.5760 (Jan 14, 2026), with a median of $3.1040 per ML.
Are there cheaper alternatives to PREDNISONE INTENSOL 5 MG/ML?
No other NADAC-published product currently shares the active ingredient and strength of PREDNISONE INTENSOL 5 MG/ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PREDNISONE INTENSOL 5 MG/ML?
PREDNISONE INTENSOL 5 MG/ML (NDC 00054372144) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.